These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24725541)

  • 1. An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis.
    Demyanets S; Tentzeris I; Jarai R; Katsaros KM; Farhan S; Wonnerth A; Weiss TW; Wojta J; Speidl WS; Huber K
    Cytokine; 2014 Jun; 67(2):65-70. PubMed ID: 24725541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K; Li YJ; Gao S
    Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction).
    Loh JP; Pendyala LK; Kitabata H; Torguson R; Omar A; Minha S; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(11):1794-801. PubMed ID: 24837256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preprocedural red blood cell distribution width predicts bare metal stent restenosis.
    Yildiz A; Tekiner F; Karakurt A; Sirin G; Duman D
    Coron Artery Dis; 2014 Sep; 25(6):469-73. PubMed ID: 24614629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis.
    Drozd J; Wójcik J; Małek R; Korona B; Zapolski T; Wysokiński A
    Kardiol Pol; 2010 Jun; 68(6):637-45. PubMed ID: 20806192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of peripheral blood eosinophil count in predicting in-stent restenosis in patients with stable angina pectoris undergoing drug eluting stenting.
    Hajizadeh R; Ghaffari S; Separham A; Shokouhi B; Kavandi H; Pourafkari L; Nader ND
    Rom J Intern Med; 2017 Dec; 55(4):229-236. PubMed ID: 28672766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between fibrinogen-to-albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
    Chen T; Sun JL; Zhang J
    Coron Artery Dis; 2020 Nov; 31(7):586-589. PubMed ID: 32271235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
    Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
    Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
    Magalhaes MA; Minha S; Chen F; Torguson R; Omar AF; Loh JP; Escarcega RO; Lipinski MJ; Baker NC; Kitabata H; Ota H; Suddath WO; Satler LF; Pichard AD; Waksman R
    Circ Cardiovasc Interv; 2014 Dec; 7(6):768-76. PubMed ID: 25466551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.
    Rathore S; Kinoshita Y; Terashima M; Katoh O; Matsuo H; Tanaka N; Kimura M; Tsuchikane E; Nasu K; Ehara M; Asakura K; Asakura Y; Suzuki T
    EuroIntervention; 2010 Feb; 5(7):841-6. PubMed ID: 20142201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bare metal stent restenosis is not a benign clinical entity.
    Chen MS; John JM; Chew DP; Lee DS; Ellis SG; Bhatt DL
    Am Heart J; 2006 Jun; 151(6):1260-4. PubMed ID: 16781233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin type 1 receptor A1166C gene polymorphism is associated with endothelial dysfunction and in-stent restenosis after percutaneous coronary intervention.
    Li Y; Chen F; Zhang X; Gao Y; Wu C; Li H; Zhang Y
    Int J Clin Exp Pathol; 2015; 8(6):7350-7. PubMed ID: 26261635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends and Outcomes of Restenosis After Coronary Stent Implantation in the United States.
    Moussa ID; Mohananey D; Saucedo J; Stone GW; Yeh RW; Kennedy KF; Waksman R; Teirstein P; Moses JW; Simonton C
    J Am Coll Cardiol; 2020 Sep; 76(13):1521-1531. PubMed ID: 32972528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do.
    Wang P; Qiao H; Wang R; Hou R; Guo J
    BMC Cardiovasc Disord; 2020 Dec; 20(1):510. PubMed ID: 33276720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing the spectrum of in-stent restenosis: implications for contemporary treatment.
    Pate GE; Lee M; Humphries K; Cohen E; Lowe R; Fox RS; Teskey R; Buller CE
    Can J Cardiol; 2006 Dec; 22(14):1223-9. PubMed ID: 17151772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary CT angiography (CCTA) using third-generation dual-source CT for ruling out in-stent restenosis.
    Eckert J; Renczes-Janetzko P; Schmidt M; Magedanz A; Voigtländer T; Schmermund A
    Clin Res Cardiol; 2019 Apr; 108(4):402-410. PubMed ID: 30187179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of the CHA2DS2-VASc Score in Predicting In-Stent Restenosis Among Patients Undergoing Revascularization With Bare-Metal Stents.
    Kurtul A
    Clin Appl Thromb Hemost; 2018 May; 24(4):589-595. PubMed ID: 28675046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship Between Lymphocyte-to-Monocyte Ratio and Bare-Metal Stent In-Stent Restenosis in Patients With Stable Coronary Artery Disease.
    Murat SN; Yarlioglues M; Celik IE; Kurtul A; Duran M; Kilic A; Oksuz F
    Clin Appl Thromb Hemost; 2017 Apr; 23(3):235-240. PubMed ID: 26759373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentration of insulin-like growth factor-I, but not tumor necrosis factor-alpha, measured twelve months after stenting of the infarct-related artery, is associated with in-stent restenosis.
    Szkodzinski J; Hudzik B; Romanowski W; Wilczek K; Danikiewicz A; Gasior M; Polonski L; Zubelewicz-Szkodzinska B
    J Biol Regul Homeost Agents; 2010; 24(2):149-56. PubMed ID: 20487628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.